On June 29, the National Medical Insurance Bureau officially announced the work plan for the adjustment of the drug catalogue of national basic medical insurance, work injury insurance and maternity insurance in 2022, the application guide for the adjustment of the drug catalogue of national basic medical insurance, work injury insurance and maternity insurance in 2022, the rules for the renewal of negotiated drugs and the rules for the bidding of non exclusive drugs, marking the official start of the adjustment of the medical insurance catalogue this year. According to the work arrangement, the adjustment of the National Drug Catalogue in 2022 is divided into five stages: preparation, application, expert review, negotiation / bidding, and publication of the results. In November, the adjustment results of the drug catalogue will be published, the documents on the catalogue adjustment will be issued, and the new version of the drug catalogue will be published. It is reported that since the establishment of the national medical insurance administration in 2018, it has carried out four consecutive negotiations on the access to the list of medical insurance drugs, and a total of 250 drugs have been added to the list through negotiations, with an average price drop of more than 50%. In 2021, 140million people were reimbursed for 221 negotiated drugs during the agreement period, with an average actual reimbursement ratio of 68.7%. Through negotiation on price reduction and medical insurance reimbursement, a total of 1494.49 billion yuan was reduced for patients during the year. (outlook new era)